MARKET RADAR
SENSEX     NIFTY      Refresh

Franklin Pharma Fund (D)

32.609
0.13 (0.40%)
NAV as on Sep-09-2011

Fund Family Franklin Templeton Mutual Fund

Fund Class

Not Ranked

This scheme is not ranked by CRISIL.
View Top ranked funds in other categories

View Historic Graph From     To     

Returns (NAV as on Sep-09-2011)

Period Returns (%) Rank #
1 mth - -
3 mth - -
6 mth - -
1 year - -
2 year - -
3 year - -
5 year - -

# Moneycontrol Rank within 35 Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2011 -6.2 5.4 -5.3 - -6.1
2010 13.0 7.3 3.9 6.1 36.6
2009 -0.8 37.5 31.6 19.7 111.2
2008 -13.3 4.8 1.2 -20.8 -27.4
2007 -1.9 11.8 -11.8 -6.0 -9.8

View where it stands within its peers

* Returns over 1 year are Annualised

Performance

Fund returns v/s Category average ()

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns -- -- -- -- -- -- --
Category avg 0.6 -7.9 10.1 -27.3 -- -- --
Difference of Fund returns and Category returns -- -- -- -- -- -- --
Best of category -6.1 -7.9 -6.6 -27.3 -- -- --
Worst of category 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Investment Info

Investment Objective

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Mar 31, 1999
Benchmark N.A
Asset Size (Rs cr) 63.51 (Sep-30-2011)
Minimum Investment Rs.5000
Last Dividend Rs.2.50 (Oct-24-2007)
Bonus N.A.
Fund Manager Anand Radhakrishnan
View performance of schemes managed by the Fund Manager
Notes Franklin Pharma Fund has been merged with Franklin India Prima Plus w.e.f. September 9, 2011.

Load Details

Entry Load N.A
Exit Load 1.00%
Load Comments Exit Load 1% if units are redeemed / switched-out within 1 year from the date of allotment.

Contact Details

Regd. Office Sakhar Bhavan, 1st Floor, 230, Backbay Reclamation, Nariman Point, Mumbai, 400021
Tel. No. 66325820-36
Fax No. 22886707/22886133
Email mktg@templeton.com
Website http://www.franklintempletonindia.com

Peer Comparison

Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Sundaram Capex Oppor.- IP (G) Not Ranked
0.32 0.0 0.0 -- -- --
ICICI Pru Real Est-Sec -RP (G) Not Ranked
303.28 0.0 0.0 -- -- --
Mirae Ultra STBF - SIP (G) Not Ranked
257.04 0.0 0.0 -- -- --
Mirae Liquid Fund - SIP (G) Not Ranked
231.07 0.0 0.0 -- -- --
Templeton (I) TMA- Liquid (G) Not Ranked
41.93 0.0 0.0 -- -- --
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (Aug 30, 11)

Equity Sector Value
(Rs cr)
Asset %
Cadila Health Pharmaceuticals 14.23 10.63
Dr Reddys Labs Pharmaceuticals 12.10 9.04
Lupin Pharmaceuticals 11.47 8.57
Ipca Labs Pharmaceuticals 9.42 7.04
Pfizer Pharmaceuticals 8.94 6.68
Wyeth Pharmaceuticals 8.47 6.33
Torrent Pharma Pharmaceuticals 7.79 5.82
Sun Pharma Pharmaceuticals 7.35 5.49
Apollo Hospital Services 6.15 4.59
Cipla Pharmaceuticals 5.46 4.08

Full Portfolio

Sector Allocation (Aug 30, 11)

Sector %

1-Year

HighLow

Pharmaceuticals 70.83 83.62 70.83
Services 5.06 5.06 4.24
Food & Beverage 3.94 3.94 2.02

View All Sectors

Asset Allocation (%)(Aug 30, 11)

Equity 79.83
Others 0.00
Debt 0.18
Mutual Funds N.A
Money Market 0.00
Cash / Call 19.99

View All

Concentration

Holdings (%)
Top 5 41.96
Top 10 68.27
Sector (%)
Top 3 79.83

News & Videos

News

Messages & Community